DAFORMFILLABLE.COM | DA FORM 7424 Fillable – Army Pubs 7424 PDF – DA FORM 7424, also known as the Sensitive Duty Assignment Eligibility Questionnaire, is a crucial document within the U.S. Army, designed to assess the eligibility of individuals for sensitive duty assignments. This article aims to provide an informative and educational overview of DA FORM 7424, ensuring a comprehensive understanding of its purpose, application, and importance.
DA FORM 7424 – Sensitive Duty Assignment Eligibility Questionnaire
Form Number | DA FORM 7424 |
Form Title | Sensitive Duty Assignment Eligibility Questionnaire |
Form Date | 5/1/2019 |
Form Proponent | G-1 |
What is DA FORM 7424?
DA FORM 7424 is an official form issued by the Department of the Army, specifically designed to evaluate the suitability of personnel for assignments that require access to sensitive information or positions of high responsibility. The form’s primary objective is to ensure that only eligible and reliable individuals are assigned to roles that could impact national security or sensitive operations.
Publication and Status
- Pub/Form Number: DA FORM 7424
- Pub/Form Date: 05/01/2019
- Pub/Form Title: Sensitive Duty Assignment Eligibility Questionnaire
- Pub/Form Proponent: G-1
- Pub/Form Status: ACTIVE
Importance of DA FORM 7424
The Sensitive Duty Assignment Eligibility Questionnaire plays a pivotal role in maintaining the integrity and security of sensitive positions within the Army. By thoroughly assessing an individual’s background, qualifications, and suitability, the Army ensures that only those who meet stringent criteria are entrusted with sensitive duties.
Prescribing Directive and Privacy Act
The use and application of DA FORM 7424 are governed by AR 614-200. It’s important to note that this form is produced exclusively in electronic media and requires a Privacy Act Statement in accordance with AR 340-21. This ensures that personal data is handled with the utmost confidentiality and privacy.
Key Sections of DA FORM 7424
1. Personal Information
This section collects basic personal details of the applicant, including name, rank, and social security number. Accurate information is essential for proper identification and assessment.
2. Eligibility Criteria
The questionnaire includes various questions that help determine the individual’s eligibility for sensitive assignments. These questions cover aspects such as previous assignments, disciplinary records, and security clearance status.
3. Certifications and Approvals
The final section of the form requires signatures from the applicant and the approving authority. This certification process ensures that all information provided is accurate and verified.
Security Classification and Distribution
DA FORM 7424 is classified as UNCLASSIFIED, which means it does not contain sensitive information that requires special handling or protection. The distribution code A signifies that the form is approved for public release and can be distributed without restrictions.
Revisions and Supersession
The current version of DA FORM 7424, dated 05/01/2019, revised the previous version dated 07/01/2009. This update ensures that the form remains relevant and in line with current regulations and requirements.
Utilizing DA FORM 7424
For individuals and officials tasked with completing or processing DA FORM 7424, it is crucial to follow the guidelines provided in AR 614-200 meticulously. Ensuring the accuracy and completeness of the form is essential for maintaining the integrity of the sensitive duty assignment process.
Conclusion
In summary, DA FORM 7424 – Sensitive Duty Assignment Eligibility Questionnaire is an essential tool for evaluating the suitability of personnel for sensitive assignments within the Army. By adhering to the prescribed guidelines and ensuring accurate information, the Army can maintain the security and effectiveness of its operations. This form, governed by AR 614-200 and protected under the Privacy Act, is a testament to the Army’s commitment to national security and operational integrity.
For more detailed information, individuals are encouraged to refer to the official prescribing directive, AR 614-200, and ensure compliance with all relevant guidelines when handling DA FORM 7424.